Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company" or "Rapid Micro"), an innovative life sciences technology company providing mission critical ...
OPKO Health, Inc.: OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth ...
Berenberg analyst Luisa Hector lowered the firm’s price target on Merck (MRK) to $115 from $125 and keeps a Buy rating on the shares. Merck ...
BankPlus Trust Department recently acquired 6,037 shares of Merck & Co., Inc., valued at $601,000, during Q4. Several ...
Eli Lilly and Company, Hims & Hers Health, UnitedHealth Group, Walmart, Tempus AI, Johnson & Johnson, and Merck & Co., Inc. are the seven Medical stocks to watch today, according to MarketBeat’s stock ...
Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc., JD.com, and AstraZeneca are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical ...
Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisors IRDr.
Merck Forest & Farmland Center (MFFC) announces the appointment of Tom O’Handley as its new Senior Director of Development.
Merck & Co. Inc. closed 32.72% below its 52-week high of $134.63, which the company achieved on June 25th.
A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened ...
As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results